Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
Recruiting · NCT04855773 · Interventional (participants receive a specific treatment) · Lead sponsor: Public Health Foundation Enterprises, Inc.
View the official record on ClinicalTrials.gov →Interventions studied
Dot DiaryPrEPmate
What this trial is about
The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV pre-exposure prophylaxis (PrEP) as directed by the clinic. PrEP is the use of a daily anti-HIV medications by HIV-negative people to help prevent HIV infection.
Who can take part
Age range
15 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Self-identifies as a cisgender man, transgender man (assigned female at birth, trans-masculine spectrum), or transgender woman (assigned male sex at birth, trans-feminine spectrum)
- Report sex with a cisgender man or transgender woman or any individual assigned male sex at birth in the past 12 months
- Age 15 years or older
- Willing and able to provide written informed consent
- Owns an iOS or Android mobile phone and able to access the internet and send and receive text messages
- Able to understand, read, and speak English or Spanish
- Newly initiated PrEP or currently on PrEP and at risk for PrEP discontinuation based on at least one of the following:
- Initiated PrEP within the past 6 months, or
- Has any of the following risk factors for PrEP discontinuation: missed clinic visits; age \< 30; African-American or Latino; transgender gender identity; or self-reported illicit substance use
Exclusion criteria
- Currently enrolled in another PrEP intervention study
- Unable to complete 12 month study participation
- Any medical, psychiatric, or social condition or other responsibilities that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
Where it is running
4 locations listed across 3 US states.
- Bridge HIV, San Francisco Department of Public Health - San Francisco, California, United States
- San Francisco AIDS Foundation - San Francisco, California, United States
- Whitman-Walker Health - Washington D.C., District of Columbia, United States
- University of Miami - Miami, Florida, United States